PPM1D mutations are more commonly found in patients with therapy-related myelodysplastic syndrome than primary myelodysplastic syndrome (15% versus 3%) and are associated with shorter survival after hematopoietic stem cell transplantation. The gene discussed is PPM1D; the disease is myelodysplastic syndrome.